Drug Type Probiotics |
Synonyms DSM-6595 |
Target- |
Action modulators |
Mechanism Bacteria replacements, Microbiome modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Graft Versus Host Disease | Phase 3 | United States | 30 Apr 2018 | |
Acute Graft Versus Host Disease | Phase 3 | Canada | 30 Apr 2018 | |
Leukemia | Phase 3 | United States | 30 Apr 2018 | |
Leukemia | Phase 3 | Canada | 30 Apr 2018 | |
Lymphoma | Phase 3 | United States | 30 Apr 2018 | |
Lymphoma | Phase 3 | Canada | 30 Apr 2018 | |
Graft vs Host Disease | Phase 3 | - | - |
Phase 3 | 173 | Allogeneic Hematopoietic Stem Cell Transplantation+Lactobacillus plantarum strain 299v (Arm I (Lactobacillus Plantarum, alloHCT)) | mpeuatksef = jwmqxgdyhm wmdrdabnwa (htjlxvazky, omzkkjqlpu - bgteoudvrk) View more | - | 17 Jul 2023 | ||
Allogeneic Hematopoietic Stem Cell Transplantation (Arm II (Placebo, alloHCT)) | mpeuatksef = fytajyyigc wmdrdabnwa (htjlxvazky, dhhueliztw - dfefdkqdaf) View more |